These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35809032)

  • 1. Secondary Sclerosing Cholangitis Following Coronavirus Disease 2019 (COVID-19): A Multicenter Retrospective Study.
    Hunyady P; Streller L; Rüther DF; Groba SR; Bettinger D; Fitting D; Hamesch K; Marquardt JU; Mücke VT; Finkelmeier F; Sekandarzad A; Wengenmayer T; Bounidane A; Weiss F; Peiffer KH; Schlevogt B; Zeuzem S; Waidmann O; Hollenbach M; Kirstein MM; Kluwe J; Kütting F; Mücke MM
    Clin Infect Dis; 2023 Feb; 76(3):e179-e187. PubMed ID: 35809032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients.
    Leonhardt S; Jürgensen C; Frohme J; Grajecki D; Adler A; Sigal M; Leonhardt J; Voll JM; Kruse JM; Körner R; Eckardt KU; Janssen HJ; Gebhardt V; Schmittner MD; ; Frey C; Müller-Ide H; Bauer M; Thibeault C; Kurth F; Sander LE; Müller T; Tacke F
    Hepatol Int; 2023 Dec; 17(6):1610-1625. PubMed ID: 37119516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?
    Bartoli A; Cursaro C; Seferi H; Andreone P
    Hepat Med; 2023; 15():93-112. PubMed ID: 37547355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
    Kirstein MM; Book T; Manns MP; von Hahn T; Voigtländer T
    United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-glutamyltransferase is a strong predictor of secondary sclerosing cholangitis after lung transplantation for COVID-19 ARDS.
    Schwarz S; Lang C; Harlander M; Štupnik T; Slambrouck JV; Ceulemans LJ; Ius F; Gottlieb J; Kuhnert S; Hecker M; Aigner C; Kneidinger N; Verschuuren EA; Smits JM; Tschernko E; Schaden E; Faybik P; Markstaller K; Trauner M; Jaksch P; Hoetzenecker K
    J Heart Lung Transplant; 2022 Oct; 41(10):1501-1510. PubMed ID: 35907758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases.
    Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Eurich D; Faber W; Neuhaus P; Seehofer D
    Medicine (Baltimore); 2015 Dec; 94(49):e2188. PubMed ID: 26656347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary Sclerosing Cholangitis due to Severe COVID-19: An Emerging Disease Entity?
    Seifert M; Kneiseler G; Dechene A
    Digestion; 2023; 104(4):306-312. PubMed ID: 36889285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for critically Ill patients with secondary sclerosing cholangitis: Outcome and complications.
    Voigtländer T; Jaeckel E; Lehner F; Manns MP; Lankisch TO
    Liver Transpl; 2015 Oct; 21(10):1295-9. PubMed ID: 26069199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients.
    Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Hetzer R; Schaffartzik W; Tryba M; Neuhaus P; Seehofer D
    Crit Care; 2015 Mar; 19(1):131. PubMed ID: 25886728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19.
    Bütikofer S; Lenggenhager D; Wendel Garcia PD; Maggio EM; Haberecker M; Reiner CS; Brüllmann G; Buehler PK; Gubler C; Müllhaupt B; Jüngst C; Morell B
    Liver Int; 2021 Oct; 41(10):2404-2417. PubMed ID: 34018314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BISCIT: Biliary interventions in critically ill patients with secondary sclerosing cholangitis-a study protocol for a multicenter, randomized, controlled parallel group trial.
    Stahl K; Klein F; Voigtländer T; Großhennig A; Book T; Müller T; Wree A; Kuellmer A; Weigt J; Dechene A; Wedi E; Kandulski A; Lange CM; Holzwart D; von Witzendorff D; Ringe KI; Wedemeyer H; Heidrich B;
    Trials; 2023 Mar; 24(1):247. PubMed ID: 37004078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary sclerosing cholangitis after COVID-19 pneumonia: a report of two cases and review of the literature.
    Bauer U; Pavlova D; Abbassi R; Lahmer T; Geisler F; Schmid RM; Ehmer U
    Clin J Gastroenterol; 2022 Dec; 15(6):1124-1129. PubMed ID: 35953614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary sclerosing cholangitis following major burn.
    Ben-Ari Z; Levingston D; Weitzman E; Haviv-Yadid Y; Cohen-Ezra O; Weiss P; Zuckerman E; Inbar Y; Amitai M; Rimon U; Goder M; Haik J
    Ann Hepatol; 2015; 14(5):695-701. PubMed ID: 26256898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary sclerosing cholangitis.
    Ruemmele P; Hofstaedter F; Gelbmann CM
    Nat Rev Gastroenterol Hepatol; 2009 May; 6(5):287-95. PubMed ID: 19404269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary sclerosing cholangitis in critically ill patients: current perspectives.
    Gudnason HO; Björnsson ES
    Clin Exp Gastroenterol; 2017; 10():105-111. PubMed ID: 28694703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis.
    John BV; Bastaich D; Webb G; Brevini T; Moon A; Ferreira RD; Chin AM; Kaplan DE; Taddei TH; Serper M; Mahmud N; Deng Y; Chao HH; Sampaziotis F; Dahman B
    J Intern Med; 2023 May; 293(5):636-647. PubMed ID: 37018129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge issues in juvenile sclerosing cholangitis.
    Di Giorgio A; Vergani D; Mieli-Vergani G
    Dig Liver Dis; 2022 Apr; 54(4):417-427. PubMed ID: 34289942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Secondary Sclerosing Cholangitis in Hospitalized Long COVID-19 Patients: A Retrospective Single Center Study.
    Werner CR; Fusco S; Kienzle K; Döbele S; Artzner K; Malek NP; Wichmann D; Göpel S
    Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiological analysis of bile and its impact in critically ill patients with secondary sclerosing cholangitis.
    Voigtländer T; Leuchs E; Vonberg RP; Solbach P; Manns MP; Suerbaum S; Lankisch TO
    J Infect; 2015 May; 70(5):483-90. PubMed ID: 25659761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary sclerosing cholangitis in a young COVID-19 patient resulting in death: A case report.
    Steiner J; Kaufmann-Bühler AK; Fuchsjäger M; Schemmer P; Talakić E
    World J Gastrointest Surg; 2022 Dec; 14(12):1411-1417. PubMed ID: 36632122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.